Dextera Surgical (DXTR) Earns Daily Media Sentiment Score of 0.12

Media headlines about Dextera Surgical (NASDAQ:DXTR) have trended somewhat positive on Tuesday, Accern reports. The research group identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dextera Surgical earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned media stories about the medical instruments supplier an impact score of 46.4883840282481 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Dextera Surgical (NASDAQ:DXTR) opened at $0.14 on Tuesday. Dextera Surgical has a 12-month low of $0.11 and a 12-month high of $2.33.

Dextera Surgical (NASDAQ:DXTR) last released its earnings results on Thursday, November 9th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.02). The firm had revenue of $0.69 million for the quarter, compared to analyst estimates of $0.62 million. research analysts anticipate that Dextera Surgical will post -0.25 earnings per share for the current year.

DXTR has been the topic of several recent research reports. Zacks Investment Research raised shares of Dextera Surgical from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 10th. Ladenburg Thalmann Financial Services started coverage on shares of Dextera Surgical in a research note on Wednesday, August 16th. They issued a “buy” rating and a $0.80 target price for the company.

ILLEGAL ACTIVITY NOTICE: “Dextera Surgical (DXTR) Earns Daily Media Sentiment Score of 0.12” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/05/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-dextera-surgical-dxtr-stock-price.html.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Insider Buying and Selling by Quarter for Dextera Surgical (NASDAQ:DXTR)

Receive News & Ratings for Dextera Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply